MarketCapTrends
VYGR
Voyager Therapeutics Inc. (VYGR)
NASDAQ · Healthcare

Voyager Therapeutics Inc. Total Liabilities 2015–2025

Voyager Therapeutics Inc. annual/quarterly total liabilities history from 2015 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Voyager Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 56.2M, a 39.76% decrease year-over-year.
  • Voyager Therapeutics Inc. total liabilities for 2025 were 56.2M, a 39.76% decrease from 2024.
  • Voyager Therapeutics Inc. total liabilities for 2024 were 93.3M, a 18.85% decrease from 2023.
  • Voyager Therapeutics Inc. total liabilities for 2023 were 115.0M, a 14.58% increase from 2022.
  • Voyager Therapeutics Inc. total liabilities for 2022 were 100.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Voyager Therapeutics Inc. Annual Total Liabilities (Millions of US $)
2025$56
2024$93
2023$115
2022$100
2021$99
2020$107
2019$255
2018$131
2017$50
2016$54
2015$60
Voyager Therapeutics Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$56
2024-12-31$93
2023-12-31$115
2022-12-31$100
2021-12-31$99
2020-12-31$107
2019-12-31$255
2018-12-31$131
2017-12-31$50
2016-12-31$54
2015-12-31$60

Voyager Therapeutics Inc. Total Liabilities — FAQ

Voyager Therapeutics Inc. (VYGR) total liabilities over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VYGR's total liabilities history?

The chart and table above show Voyager Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.